• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov8
Barinthus Biotherapeutics released FY2025 Q3 earnings on November 7 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -0.3599 (forecast USD -0.45)
04:00
Barinthus Biotherapeutics released FY2025 9 Months Earnings on November 7, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.3736
04:00
Nov7
Barinthus Bio Merges with Clywedog to Create Clywedog Therapeutics
12:30
Aug8
Barinthus Biotherapeutics released FY2025 Semi-Annual Earnings on August 7 (EST), actual revenue USD 0, actual EPS USD -1.0115
03:00
Barinthus Biotherapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.5236 (forecast USD -0.33)
03:00
May8
Barinthus Biotherapeutics released FY2025 Q1 earnings on May 7 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.49 (forecast USD -0.335)
03:00

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -14.57 M, EPS -0.3599

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.12 M, EPS -0.5236

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -19.65 M, EPS -0.49

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ATGL
21.610
+139.84%
+12.600
AMIX
1.150
+58.18%
+0.423
FSHPR
0.1900
+58.07%
+0.070
SGBX
3.220
+49.77%
+1.070
PACS
15.700
+48.39%
+5.120
SSP
4.280
+39.87%
+1.220
ICG
1.390
+32.38%
+0.340
SGML
8.020
+32.34%
+1.960
RPTX
2.180
+32.12%
+0.530
YDDL
5.220
+31.82%
+1.260
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy